Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-23

Clinical Trial Update: Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer

View source ↗

Summary

A clinical trial update investigating patient satisfaction with an oral anti-cancer treatment in patients with ER-positive, HER2-negative advanced breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KU Leuven | Conditions: ER Positive, HER2 Negative Breast Cancer Neoplasms | Status: UNKNOWN